Cargando…

Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review

OBJECTIVES: To identify published closed-loop Bayesian mixed treatment comparisons (MTCs) and to summarise characteristics regarding their conduct and reporting. DESIGN: Systematic review. METHODS: We searched multiple bibliographic databases (January 2006–31 July 2011) for full-text, English langua...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobieraj, Diana M, Cappelleri, Joseph C, Baker, William L, Phung, Olivia J, White, C Michael, Coleman, Craig I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717466/
https://www.ncbi.nlm.nih.gov/pubmed/23878173
http://dx.doi.org/10.1136/bmjopen-2013-003111
_version_ 1782277697303478272
author Sobieraj, Diana M
Cappelleri, Joseph C
Baker, William L
Phung, Olivia J
White, C Michael
Coleman, Craig I
author_facet Sobieraj, Diana M
Cappelleri, Joseph C
Baker, William L
Phung, Olivia J
White, C Michael
Coleman, Craig I
author_sort Sobieraj, Diana M
collection PubMed
description OBJECTIVES: To identify published closed-loop Bayesian mixed treatment comparisons (MTCs) and to summarise characteristics regarding their conduct and reporting. DESIGN: Systematic review. METHODS: We searched multiple bibliographic databases (January 2006–31 July 2011) for full-text, English language publications of Bayesian MTCs comparing the effectiveness or safety of ≥3 interventions based on randomised controlled trials and having at least one closed loop. Methodological and reporting characteristics of MTCs were extracted in duplicate and summarised descriptively. RESULTS: We identified 34 Bayesian MTCs spanning 13 clinical areas. Publication of MTCs increased over the 5-year period; with 76.5% published during or after 2009. MTCs included a mean (±SD) of 35.9±30.1 trials (n=33 459±71 233 participants) and 8.5±4.3 interventions (85.7% pharmacological). Non-informative and informative prior distributions were reported to be used in 44.1% and 8.8% of MTCs, respectively, with the remainder failing to specify the prior used. A random-effects model was used to analyse the networks of trials in 58.5% of MTCs, all using WinBUGS; however, code was infrequently provided (20.6%). More than two-thirds of MTCs (76.5%) also conducted traditional meta-analysis. Methods used to evaluate convergence, heterogeneity and inconsistency were infrequently reported, but from those providing detail, methods appeared varied. MTCs most often used a binary effect measure (85.3%) and ranking of interventions based on probability was common (61.8%), although rarely displayed in a figure (8.8% of MTCs). MTCs were published in 24 different journals with a mean impact factor of 9.20±8.71. While 70.8% of journals imposed limits on word counts and 45.8% limits on the number of tables/figures, online supplements/appendices were allowed in 79.2% of journals. Publication of closed-loop Bayesian MTCs is increasing in frequency, but details regarding their methodology are often poorly described. Efforts in clarifying the appropriate methods and reporting of Bayesian MTCs should be of priority.
format Online
Article
Text
id pubmed-3717466
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-37174662013-07-22 Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review Sobieraj, Diana M Cappelleri, Joseph C Baker, William L Phung, Olivia J White, C Michael Coleman, Craig I BMJ Open Evidence Based Practice OBJECTIVES: To identify published closed-loop Bayesian mixed treatment comparisons (MTCs) and to summarise characteristics regarding their conduct and reporting. DESIGN: Systematic review. METHODS: We searched multiple bibliographic databases (January 2006–31 July 2011) for full-text, English language publications of Bayesian MTCs comparing the effectiveness or safety of ≥3 interventions based on randomised controlled trials and having at least one closed loop. Methodological and reporting characteristics of MTCs were extracted in duplicate and summarised descriptively. RESULTS: We identified 34 Bayesian MTCs spanning 13 clinical areas. Publication of MTCs increased over the 5-year period; with 76.5% published during or after 2009. MTCs included a mean (±SD) of 35.9±30.1 trials (n=33 459±71 233 participants) and 8.5±4.3 interventions (85.7% pharmacological). Non-informative and informative prior distributions were reported to be used in 44.1% and 8.8% of MTCs, respectively, with the remainder failing to specify the prior used. A random-effects model was used to analyse the networks of trials in 58.5% of MTCs, all using WinBUGS; however, code was infrequently provided (20.6%). More than two-thirds of MTCs (76.5%) also conducted traditional meta-analysis. Methods used to evaluate convergence, heterogeneity and inconsistency were infrequently reported, but from those providing detail, methods appeared varied. MTCs most often used a binary effect measure (85.3%) and ranking of interventions based on probability was common (61.8%), although rarely displayed in a figure (8.8% of MTCs). MTCs were published in 24 different journals with a mean impact factor of 9.20±8.71. While 70.8% of journals imposed limits on word counts and 45.8% limits on the number of tables/figures, online supplements/appendices were allowed in 79.2% of journals. Publication of closed-loop Bayesian MTCs is increasing in frequency, but details regarding their methodology are often poorly described. Efforts in clarifying the appropriate methods and reporting of Bayesian MTCs should be of priority. BMJ Publishing Group 2013-07-19 /pmc/articles/PMC3717466/ /pubmed/23878173 http://dx.doi.org/10.1136/bmjopen-2013-003111 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Evidence Based Practice
Sobieraj, Diana M
Cappelleri, Joseph C
Baker, William L
Phung, Olivia J
White, C Michael
Coleman, Craig I
Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review
title Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review
title_full Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review
title_fullStr Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review
title_full_unstemmed Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review
title_short Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review
title_sort methods used to conduct and report bayesian mixed treatment comparisons published in the medical literature: a systematic review
topic Evidence Based Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717466/
https://www.ncbi.nlm.nih.gov/pubmed/23878173
http://dx.doi.org/10.1136/bmjopen-2013-003111
work_keys_str_mv AT sobierajdianam methodsusedtoconductandreportbayesianmixedtreatmentcomparisonspublishedinthemedicalliteratureasystematicreview
AT cappellerijosephc methodsusedtoconductandreportbayesianmixedtreatmentcomparisonspublishedinthemedicalliteratureasystematicreview
AT bakerwilliaml methodsusedtoconductandreportbayesianmixedtreatmentcomparisonspublishedinthemedicalliteratureasystematicreview
AT phungoliviaj methodsusedtoconductandreportbayesianmixedtreatmentcomparisonspublishedinthemedicalliteratureasystematicreview
AT whitecmichael methodsusedtoconductandreportbayesianmixedtreatmentcomparisonspublishedinthemedicalliteratureasystematicreview
AT colemancraigi methodsusedtoconductandreportbayesianmixedtreatmentcomparisonspublishedinthemedicalliteratureasystematicreview